Market Overview

US Stock Futures Edge Lower Ahead Of ADP Report, FOMC Minutes

Share:
US Stock Futures Edge Lower Ahead Of ADP Report, FOMC Minutes
Related VRX
TD Ameritrade Index Indicates Retail Investors Are At Their Most Bullish Point Yet
Investor Movement Index December Summary
Overlooked competition looming for Valeant's Xifaxan - Wells Fargo (Seeking Alpha)
Related TSCO
Favorable Weather Conditions Isn't Enough To Keep This Analyst Bullish On Tractor Supply Company
Benzinga's Top Upgrades, Downgrades For January 11, 2018
Tractor Supply Company to Webcast Fourth Quarter and Full Year —…–7 Results (GuruFocus)

Pre-open movers

US stock futures traded slightly lower in early pre-market trade. The ADP national employment report for December will be released at 8:30 a.m. ET. The Federal Open Market Committee will issue minutes of its latest meeting at 2:00 p.m. ET, while consumer credit data for November will be released at 3:00 p.m. ET. Futures for the Dow Jones Industrial Average tumbled 11 points to 16,443.00, while the Standard & Poor's 500 index futures dropped 1.40 points to 1,829.30. Futures for the Nasdaq 100 index fell 2 points to 3,546.75.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index falling 0.17%, London's FTSE 100 index dropping 0.40% and STOXX Europe 600 Index declining 0.07%. German DAX 30 index fell 0.15% and French CAC 40 Index declined 0.16%. Euro-zone retail sales climbed by 1.4% in November versus October.

Asian markets ended mostly higher today. Japan's Nikkei Stock Average surged 1.94%, China's Shanghai Composite fell 0.15%, Hong Kong's Hang Seng Index gained 1.25% and India's BSE Sensex rose 0.17%.

Broker Recommendation

Analysts at Morgan Stanley upgraded Valeant Pharmaceuticals International (NYSE: VRX) from “equal-weight” to “overweight.” The target price for Valeant Pharmaceuticals is set to $145.

Valeant's shares surged 11.30% to close at $125.35 yesterday.

Breaking news

  • Revionics announced today that Tractor Supply Company (NASDAQ: TSCO) is renewing its Revionics Price Optimization license for three years and expanding the partnership to include the use of Revionics Markdown Optimization. To read the full news, click here.
  • CAE (NYSE: CAE) today announced that it has won contracts valued at more than C$110 million, not including options, to provide a range of training systems and services for defence customers. To read the full news, click here.
  • Pluristem Therapeutics (NASDAQ: PSTI) today announced it has been granted a new patent in Australia. To read the full news, click here.
  • Cellular Dynamics (NASDAQ: ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health Sciences SA (NIHS). To read the full news, click here.

Posted-In: Federal Open Market Committee Morgan StanleyNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (CAE + ICEL)

View Comments and Join the Discussion!